FdaApplication
ANDA 203845
Identifiers
- fda_app_no: ANDA203845
Properties
| Property | Value |
|---|---|
| applicant_name | CADILA PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2014-09-18 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| HYDRALAZINE HYDROCHLORIDE | HYDRALAZINE HYDROCHLORIDE | 50MG | TABLET;ORAL |
| HYDRALAZINE HYDROCHLORIDE | HYDRALAZINE HYDROCHLORIDE | 25MG | TABLET;ORAL |
| HYDRALAZINE HYDROCHLORIDE | HYDRALAZINE HYDROCHLORIDE | 100MG | TABLET;ORAL |
3 products